Gerald L. Chan
Gerald L. Chan is co-founder and director of The Morningside Group, a private equity and venture capital investment firm. He is known for his commitment to advancing bold research that targets autoimmune diseases, microbial infections, cancers, and other maladies. He combines science and finance to create solutions for reducing the global disease burdens. In 2014, under the auspices of The Morningside Foundation, he and his family made an unprecedented gift to support public health research and teaching at Harvard University.